Max Robotics — Global Service Robot Directory + US Certification

About

Gianluigi Taverna is a leading figure in urologic oncology and robotic surgery, whose work has significantly advanced the treatment of prostate and kidney cancers. His research focuses on refining minimally invasive techniques and improving patient outcomes through precision diagnostics. Taverna’s most impactful contribution is a multi-institutional study on robot-assisted surgery for benign ureteral strictures, which has garnered 92 citations and established a benchmark for complex reconstructive procedures. He also pioneered the use of the ALF–X robot for partial nephrectomies in preclinical models, demonstrating the feasibility of novel robotic platforms. In prostate cancer, Taverna has made critical strides in risk stratification: his work on the Prostate Health Index as a predictor of early biochemical recurrence (26 citations) and his preliminary investigation into eNose urine odor analysis for cancer detection highlight his commitment to non-invasive, personalized medicine. Beyond these innovations, his studies on surgical techniques—such as the retrotrigonal sling for early continence after radical prostatectomy—reflect a dedication to improving patients’ quality of life. With a career marked by collaborative, high-impact research, Taverna continues to shape the future of urologic surgery.